Chemed Corporation

Jurisdiction

United States

LEI

54930020031IDJT2IM79

ISIN

US16359R1032

(CHE)

Sectors

Scores

InsiderPie Expert Score: 49 / 100
Even with peer group:: 51 / 100
Fair value (Benjamin Graham formula): €354.32 4.4% overvalued
Financial strength (Piotroski F-Value): 7 / 9
Fundamental strength relative to industry (Mohanram G-Value): 5 / 7

Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. Read full profile

Fundamentals

Net revenue: €2.14B
Gross margin: 32.4%
EBIT: €314.63M
EBIT margin: 14.7%
Net income: €247.65M
Net margin: 11.6%

Statement period: July 1, 2024 - June 30, 2025 (published July 29, 2025)

Estimates

Fiscal Year	Net revenue	Net income
2026	€2.32B +8.3%	€279.90M +13.0%
2027	€2.40B +3.6%	€329.46M +17.7%
	N/A	N/A

Dividends

Last dividend amount: $0.60
Ex date: August 8, 2025
Payment date: August 29, 2025
Dividend payout ratio: 14.3%

Analyst ratings

No analyst ratings available

Insider Transactions

Name	Title	Transaction Date	Shares	Price	Value
MCNAMARA KEVIN J	president and CEO	August 5, 2025	-2K	$428.55	-$857.10K
WALSH GEORGE J III	N/A	August 4, 2025	+200	$417.10	+$83.42K
Westfall Nicholas Michael	Executive Vice President	August 4, 2025	-10K	$421.91	-$4.22M